KLK3 and Familial prostate cancer: Several studies have reported that equol can decrease serum PSA levels by its antiandrogenic action on 5-alpha-dehydro testosterone, decrease prostate size, and thus reduce the risk of prostate cancer [15, 16, 43, 44].